ADVERTISEMENT
AIBD APP Institute | AIBD APP Institute Online Learning Hub
TNF Inhibitors for Treating IBD: How They Work
This video describes the pivotal role of tumor necrosis factor-alpha (TNF-alpha) inhibitors in the management of irritable bowel disease. TNF-alpha inhibitors are monoclonal antibodies that help prevent the immune system from mistakenly attacking the gastrointestinal tract, but come with the potential for immunogenicity that limits efficacy and can help bring on complications arising from infections.
View
Mechanisms of Gastrointestinal Inflammation in Crohn’s Disease and Ulcerative Colitis
This video explains the mechanisms of gastrointestinal inflammation underlying Crohn’s disease and ulcerative colitis. Viewers will learn what causes this inflammation at a cellular level and how environmental and genetic risk factors affect disease development.
View
Crohn’s Disease and Ulcerative Colitis: How Are They Different?
This video discusses how to distinguish ulcerative colitis from Crohn’s disease in patients presenting with irritable bowel disease. APPs will understand the similarities and differences between the inflammation pathways underlying these similarly presenting diseases, as well as the appropriate diagnostic tools to use for each.
View
The APP Institute is dedicated to educating and informing advanced practice providers on clinical topics and practical issues to support the profession and improve the quality of care for patients with inflammatory bowel disease.
The APP Institute | IBD is designed for Advanced Practice Providers who specialize in Inflammatory Bowel Diseases, to further their education and increase their knowledge to achieve better patient outcomes. Explore cutting-edge research, innovative treatment options, and new therapeutic methods, while remaining focused on the fundamental principles and terminology associated with IBD. Engage year-round with the AIBD Network to access clinical insights, interactive features, research news updates, accredited continuing education programs, and more.
